The Health Care Management Blog

All, Helena Posnett is currently one of the MSc International Health Management students at Imperial College Business School. She has recently setup a blog addressing topical issues within the health care and pharmaceutical industries with the hope of engaging like-minded people, like your good selves. I would encourage you to have a gander, and sign [...]

Read Full Post »

The Pfizer Persective: Pharma Careers Club Event – Thurs, Dec 2nd, 6pm at Imperial College

Andrew Bayode, Commercial Director of Wyeth (now Pfizer), share his knowledge of the challenges faced by the Industry, perspectives on future direction, and career opportunities emerging. An Imperial MBA alumnus (2002), Andrew has been working with Wyeth since 1998; first as Senior Product Manager (Oncology, Gynaecology), then as Group Product Manager (Neuroscience), and now as [...]

Read Full Post »

NHS – Is cutting costs in medical technologies worth it?

Thought this is quite apt ahead of Sir Michael Rawlins’ imminent talk…. http://news.bbc.co.uk/1/hi/health/8374275.stm

Read Full Post »

Public lecture – Sir Michael Rawlins, Chairman of NICE, Mon Nov 30th, 6pm, at NAB 107

Sir Michael Rawlins, chairman of the National Institute for Health and Clinical Excellence (NICE), will be giving a talk at the LSE on Monday, November 30th, at 6pm, NAB 107 (precise topic TBC). Sir Michael has been chairman of NICE since its formation in1999. He is also an Honorary Professor at the London School of [...]

Read Full Post »

Is Nexavar worth it?

Greetings readers, And how are we on this rather crisp, Autumnal afternoon? Well, I hope. So the perceptive amongst you will have already picked up the topic of discussion in this post – Nexavar, a drug prescribed for end-stage liver cancer. Indeed, what prompted me to write this post apart from having itchy fingers, is [...]

Read Full Post »